# A Phase I Clinical Trial of JH013 Injection

> **NCT06633055** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Biotech Pharmaceutical Co., Ltd.** · enrollment: 32 (estimated)

## Conditions studied

- Healthy Subjects (HS)

## Interventions

- **DRUG:** JH013 injection
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06633055
- **Lead sponsor:** Biotech Pharmaceutical Co., Ltd.
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-31
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-12-31
- **Target enrollment:** 32 (ESTIMATED)
- **Last updated:** 2024-10-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06633055

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06633055, "A Phase I Clinical Trial of JH013 Injection". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT06633055. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*